|
| 2017 Drug Research Roundup |
Get the latest research on the drugs
and clinical applications that concern you most |
|
|
|
 |
| It can be a struggle to keep up with important developments in therapeutics. That’s why coverage of new drug-related evidence is an important feature of NEJM Journal Watch, helping us fulfill our mission to support clinicians’ efficient understanding of medical developments. Our 110 NEJM Journal Watch physician-editors regularly appraise a broad range of medication studies, choose those with the most clinical impact, and summarize them, highlighting key points and identifying what’s new. |
| In the 2017 Drug Research Roundup, we’ve chosen summaries that address questions that arise frequently in practice — and that have helped us manage our own patients – and compiled them in a new PDF collection. This special collection is available FREE, for a limited time, when you create a free JWatch.org account. |
| Get important findings on: |
 | Tamsulosin for Patients with Ureteral Stones |
| Using TMP/SMX After Draining Uncomplicated Abscesses |
| Thiazide-Associated Hypercalcemia |
| Metformin and Vitamin B12 Deficiency |
| Warfarin for Patients with Atrial Fibrillation and Chronic Kidney Disease |
| Three Common Approaches to Smoking Cessation |
| Testosterone for Older Men |
| Association Between Proton-Pump Inhibitors and Dementia |
| Withholding ACE Inhibitors Just Before Noncardiac Surgery |
| Comparing Dabigatran, Apixaban, and Rivaroxaban |
| And more! |
|
|
Access a year’s worth of key research –
in one convenient resource. |
|
|
|
